(Reuters) – The United States is reviewing reports of a handful of potential cases of severe side effects among people who received Johnson & Johnson’s COVID-19 vaccine in addition to those that led to a pause in its use, a…
Read More
EU will have vaccine doses for 70 pct of adults by mid-July: commissioner
The EU will have enough COVID-19 vaccine doses to cover 70 percent of its adult population by mid-July due to higher production within the bloc, a senior official said Tuesday. “Fifty-three factories are producing vaccines in the EU. Our continent…
Read More
Novel mRNA delivery vehicle provides alternative to LNPs for SARS-CoV-2 vaccines
Researchers in the United States have developed an alternative messenger RNA (mRNA) delivery platform to the lipid nanoparticles that are currently used in vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019…
Read More
J&J asked other vaccine makers to join a study of blood clot risks
Johnson & Johnson asked other vaccine makers to join a study of blood clot risks, but Pfizer and Moderna DECLINED – and only AstraZeneca got on board Johnson & Johnson privately asked other vaccine manufacturers to join a study of…
Read More
EU Countries Move Toward COVID Passes to Reopen Summer Travel
BRUSSELS (Reuters) – European Union countries formally agreed on Wednesday to launch COVID travel passes as a step towards reopening to tourism this summer and will negotiate details with the bloc’s lawmakers in May, two diplomatic sources said. The certificates…
Read More
Can biomaterials offer novel therapeutic strategies against COVID-19?
The global coronavirus disease 2019 (COVID-19) pandemic rages on. To date, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, has infected over 138.3 million and caused over 2.9 million deaths the world over. Despite major gains…
Read More
US J&J Covid vaccine pause continues after experts defer vote
A pause on all US vaccinations with the Johnson & Johnson COVID shot will continue for at least another week after members of a government-convened expert panel said Wednesday they needed more time to assess its possible links to a…
Read More
Mexican-Made COVID-19 Vaccine Could Be Ready This Year
MEXICO CITY (Reuters) – Mexico aims to have developed a vaccine against COVID-19 that could be granted approval for emergency use this year, a senior official said on Tuesday, an outcome that could wean it off unreliable foreign supplies for…
Read More
Russia says Sputnik V vaccine does not cause blood clots
The developer of Russia’s Sputnik V coronavirus vaccine said Wednesday its jab did not cause blood clots, a potential side effect that has disrupted rollouts in several Western countries. The United States has recommended pausing its rollout of the Johnson…
Read More
Covid vaccine: How the AstraZeneca and Pfizer vaccines compare in effectiveness – study
Vaccine: Expert confirms over-45s can book When you subscribe we will use the information you provide to send you these newsletters. Sometimes they’ll include recommendations for other related newsletters or services we offer. Our Privacy Notice explains more about how…
Read More